[1] |
MA Shuangshuang, XING Yanjiang, ZHANG Jiawei, WANG Jing.
Research Progress on Cardiac Energy Metabolic Changes in Heart Failure with Preserved Ejection Fraction
[J]. Chinese General Practice, 2025, 28(30): 3831-3840.
|
[2] |
ZHANG Yunuo, LI Ruibin, WANG Wei.
Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(26): 3264-3270.
|
[3] |
ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei.
Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy
[J]. Chinese General Practice, 2025, 28(26): 3307-3313.
|
[4] |
TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang.
Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level
[J]. Chinese General Practice, 2025, 28(25): 3096-3103.
|
[5] |
YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan.
Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes
[J]. Chinese General Practice, 2025, 28(24): 3053-3058.
|
[6] |
WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening.
Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention
[J]. Chinese General Practice, 2025, 28(24): 2985-2992.
|
[7] |
National Clinical Research Center for Infectious Diseases Jiangxi Branch, Jiangxi Provincial Key Laboratory of Tuberculosis.
Expert Consensus on the Treatment of Pulmonary Tuberculosis Complicated with Chronic Hepatitis B Virus Infection
[J]. Chinese General Practice, 2025, 28(24): 2961-2967.
|
[8] |
LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin.
Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2852-2860.
|
[9] |
WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei.
Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(23): 2846-2851.
|
[10] |
BAI Xue, CHEN Qianqian, LI Jie.
Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2841-2845.
|
[11] |
TANG Xiaorui, XU Jingjing, GU Zijun, WANG Qingyu, LIN Zheng, ZHU Qiurui, LEI Yang.
The Reliability and Validity of the Chinese Version of Self-Care of Diabetes Inventory
[J]. Chinese General Practice, 2025, 28(21): 2643-2651.
|
[12] |
LIANG Hengmiao, HUANG Sizhe, CHEN Yuting, LIU Ce, WANG Huijun, DU Qingfeng.
A Retrospective Analysis of the Association between Serum Uric Acid Levels and Insulin Resistance Degrees in Individuals Undergoing Health Examination
[J]. Chinese General Practice, 2025, 28(21): 2635-2642.
|
[13] |
GAO Haijun, REN Jiayu, WANG Ruolin, ZHOU Huiya, QU Peng.
Research Progress on the Role of Endothelial Cell Injury and Dysfunction in Atherosclerosis
[J]. Chinese General Practice, 2025, 28(21): 2697-2704.
|
[14] |
WANG Ying, YAN Yijun, LIU Lei, HU Yumin, ZHANG Yang, LIU Kai, JIANG Boren.
Effects of Resistance Exercise Combined with Nutritional Intervention on Blood Glucose Stability in Elderly Patients with Type 2 Diabetes Mellitus with Sarcopenia
[J]. Chinese General Practice, 2025, 28(21): 2604-2610.
|
[15] |
MA Panpan, WANG Sijing, YOU Na, DING Dafa, LU Yibing.
Efficacy and Safety of Danuglipron and Orforglipron in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(21): 2679-2685.
|